T cell unresponsiveness in a pediatric cystic fibrosis patient: A case report

Allergy, Asthma and Clinical Immunology

Volumn 10, Issue 1, 2014, Pages

  Kushwah, Rahul ^a   Gagnon, Stéphane ^b   Sweezey, Neil B ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cystic fibrosis; Na ve T cells; T cell differentiation; T cell exhaustion

Indexed keywords

CORTICOSTEROID; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CHILDHOOD DISEASE; COHORT ANALYSIS; CYSTIC FIBROSIS; CYTOKINE RELEASE; DISEASE COURSE; EX VIVO STUDY; IMMUNE RESPONSE; LUNG DISEASE; LUNG TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; PROTEIN EXPRESSION; SEROLOGY; SWEAT TEST; T LYMPHOCYTE;

EID: 84892651753     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-10-2     Document Type: Article

References (27)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073. 10.1126/science.2475911, 2475911.
2. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003, 361:681-689. 10.1016/S0140-6736(03)12567-6, 12606185.
3. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187-1191. 10.1056/NEJM199204303261804, 1285737.
4. Cantin A. Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 1995, 151:939-941.
5. Bals R, Weiner DJ, Wilson JM. The innate immune system in cystic fibrosis lung disease. J Clin Invest 1999, 103:303-307. 10.1172/JCI6277, 407907, 9927489.
6. Regamey N, Tsartsali L, Hilliard TN, Fuchs O, Tan HL, Zhu J, Qiu YS, Alton EW, Jeffery PK, Bush A, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax 2012, 67:164-170. 10.1136/thoraxjnl-2011-200585, 22008188.
7. Hubeau C, Lorenzato M, Couetil JP, Hubert D, Dusser D, Puchelle E, Gaillard D. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 2001, 124:69-76. 10.1046/j.1365-2249.2001.01456.x, 1906034, 11359444.
8. Tiringer K, Treis A, Fucik P, Gona M, Gruber S, Renner S, Dehlink E, Nachbaur E, Horak F, Jaksch P, et al. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2013, 187:621-629. 10.1164/rccm.201206-1150OC, 23306544.
9. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, et al. Role of IL-17A, IL-17 F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005, 175:404-412. 2849297, 15972674.
10. Cosmi L, De PR, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R, et al. Human interleukin 17-producing cells originate from a CD161 + CD4+ T cell precursor. J Exp Med 2008, 205:1903-1916. 10.1084/jem.20080397, 2525581, 18663128.
11. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993, 159:197-207. 10.1016/0022-1759(93)90158-4, 8445253.
12. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008, 454:350-352. 10.1038/nature07021, 2760130, 18469800.
13. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4 + CD25- naive T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886. 10.1084/jem.20030152, 2194145, 14676299.
14. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006, 24:209-226. 10.1146/annurev.immunol.24.021605.090547, 16551248.
15. Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2009, 106:8623-8628. 10.1073/pnas.0809818106, 2688997, 19433785.
16. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009, 10:29-37. 10.1038/ni.1679, 2605166, 19043418.
17. Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ, Siersema PD, Hoepelman AI, van Baarle D. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS One 2013, 8:e59302. 10.1371/journal.pone.0059302, 3598709, 23555014.
18. Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y, Rosenberg W, Dusheiko G, Gilson R, Chin-Aleong J, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 2012, 7:e47648. 10.1371/journal.pone.0047648, 3480425, 23112829.
19. Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, Crompton PD, Marsh K, Ndungu FM. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol 2013, 190:1038-1047. 10.4049/jimmunol.1202438, 3549224,3549224, 23264654.
20. Gigley JP, Bhadra R, Moretto MM, Khan IA. T cell exhaustion in protozoan disease. Trends Parasitol 2012, 28:377-384. 10.1016/j.pt.2012.07.001, 3768288, 22832368.
21. Okazaki T, Okazaki IM, Wang J, Sugiura D, Nakaki F, Yoshida T, Kato Y, Fagarasan S, Muramatsu M, Eto T, et al. PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. J Exp Med 2011, 208:395-407. 10.1084/jem.20100466, 3039848, 21300912.
22. Camisaschi C, Casati C, Rini F, Perego M, De Filippo A, Triebel F, Parmiani G, Belli F, Rivoltini L, Castelli C. LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. J Immunol 2010, 184:6545-6551. 10.4049/jimmunol.0903879, 20421648.
23. Manzotti CN, Tipping H, Perry LC, Mead KI, Blair PJ, Zheng Y, Sansom DM. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol 2002, 32:2888-2896. 10.1002/1521-4141(2002010)32:10<2888:AID-IMMU2888>3.0.CO;2-F, 12355442.
24. Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. Activation of CFTR chloride current by nitric oxide in human T lymphocytes. EMBO J 1995, 14:2700-2707. 398388, 7540975.
25. Dubin PJ, Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007, 292:L519-L528. 2841977, 17071720.
26. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011, 184:252-258. 10.1164/rccm.201102-0236OC, 3381840, 21474644.
27. Kushwah R, Gagnon S, Sweezey NB. Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype. Respir Res 2013, 14:138. 10.1186/1465-9921-14-138, 3890528, 24344776.